Curcumine BIO - Gélules
Food supplement declared in France, declaration No 2022-7-481, decision dated 8 July 2022
Curcumine BIO - Gélules (Nutrixeal) is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Fibres solubles d'acacia, Curcumine. None of the rules we check flags an issue with its declared composition.
- Brand
- Nutrixeal
- Food business operator placing the product on the market
- IXEAL
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Capsule
- Daily dose
- 1 gélule par jour
- Objectives stated by the manufacturer (these are not authorised claims)
- Digestion, Detox / Drainage, Joints
Declaration 185566, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Other active ingredients
| Name | Per day |
|---|---|
| Fibres solubles d'acacia | not declared |
| Curcumine | not declared |
Other ingredients
Gélule végétale
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Label warnings
Prendre un avis médical en cas de grossesse, d’allaitement ou de traitement anticoagulant. Ne pas utiliser en cas d’intolérance au curcuma.
Regulatory points
None of the rules we check applies to the declared ingredients.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Brand : Nutrixeal
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Curcumine BIO - Gélules (Nutrixeal): composition and regulation”, https://compoatlas.com/en/supplements/products/185566-curcumine-bio-gelules, updated 15 November 2026.